Antonio Forenza was working as head of research and development at Rakuten Symphony, a telecom subsidiary of the Japanese conglomerate, when he realized that he needed to find a better way to manage his stress levels. A few years earlier, he had lost 40 pounds with the help of an Apple Watch, which counted steps […]
This startup built a Fitbit for your brain to combat chronic stress Read More »
Six years ago, I asked Sam Altman at a StrictlyVC event in San Francisco how OpenAI, with its complicated corporate structure, would make money. He said that someday, he’d ask the AI. When everyone snickered, he added, “You can laugh. It’s all right. But it really is what I actually believe.” He wasn’t kidding. Sitting
After Neuralink, Max Hodak is building something stranger Read More »
When I was 18, I bought a cheap ticket from my college class Facebook group to see Grimes perform at a nearby music festival. Amid the crowd on that sunny afternoon, a drug-addled man continuously tried to climb a young, flimsy tree for a better view. He failed again and again — it was simply
The spectacle of Bryan Johnson and his livestreamed shrooms trip Read More »
From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to connect this trove of data in a meaningful way and actually use it to improve their health. Function Health, which offers a regular lab testing
Function Health raises $298M Series B at $2.5B valuation Read More »
For Daniil Boiko and Andrei Tyrin, the idea for Onepot AI came from the same frustration. “The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is the creation of new molecules by using chemical reactions. It’s like a recipe or Lego pieces, where small pieces, ingredients, molecules, come together to form a wider puzzle picture, a food dish, a larger molecule. As
Onepot AI raises $13M to help make chemical drug creation easier Read More »
Jenny Button first thought of Emm during the COVID lockdown. She was using an Oura ring and the Whoop monitoring band and getting insights about her body, but there wasn’t a device that could provide data about one of the most important aspects — reproductive and menstrual health. “It seemed crazy to me, because these are things that every woman wants to be able to
Emm raises $9M seed to create one of the world’s first ‘smart’ menstrual cups Read More »
It’s time for day two of TechCrunch Disrupt 2025, which means San Francisco’s Moscone West will be jam-packed with another marathon of speakers, workshops, networking opportunities, and afterparties for attendees. Keep in mind that you can still register for tickets to join the excitement, and since we’re already a day in, you can get a
Disrupt 2025: Day 2 | TechCrunch Read More »
If you’ve ever had a PET scan, you know it’s an ordeal. The scans help doctors detect cancer and track its spread, but the process itself is a logistical nightmare for patients. It starts with fasting for four to six hours before coming into the hospital — and good luck to you if you live
The Enhanced Games, a new sporting competition explicitly designed to allow performance-enhancing drugs, looks like a publicity stunt for the techno-macho era: Olympic athletes on steroids competing for million-dollar bounties in Las Vegas. But co-founder Aron D’Souza has a 90% gross margin telehealth business in mind, and a pitch to governments struggling with aging populations.
Can steroids combat population collapse? The Enhanced Games wants to find out. Read More »
OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation, The New York Times reports. The fresh funds come three months after the startup raised a $210 million round at a $3.5 billion valuation, a testament to the intense investor
OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation Read More »
